DK1942868T4 - Natriumchloridopløsning til lægemiddel-rekonstitution eller -fortynding - Google Patents

Natriumchloridopløsning til lægemiddel-rekonstitution eller -fortynding Download PDF

Info

Publication number: DK1942868T4
Authority: DK; Denmark
Prior art keywords: dilution; sodium chloride; chloride solution; drug reconstitution; reconstitution
Prior art date: 2005-11-01

Application number

DK06827036.2T

Other languages

English (en)

Other versions

DK1942868T3 (da

DK1942868T5 (da

Inventor

Julie Zerfas

Chandra A Webb

Original Assignee

Wyeth Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-01

Filing date

2006-10-27

Publication date

2023-11-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37801586&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1942868(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-27 Application filed by Wyeth Llc filed Critical Wyeth Llc

2017-06-26 Publication of DK1942868T3 publication Critical patent/DK1942868T3/da

2023-11-06 Application granted granted Critical

2023-11-06 Publication of DK1942868T4 publication Critical patent/DK1942868T4/da

2024-01-08 Publication of DK1942868T5 publication Critical patent/DK1942868T5/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK06827036.2T 2005-11-01 2006-10-27 Natriumchloridopløsning til lægemiddel-rekonstitution eller -fortynding DK1942868T5 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US73222105P	2005-11-01	2005-11-01
PCT/US2006/042258 WO2007053533A2 (en)	2005-11-01	2006-10-27	Sodium chloride solution for drug reconstitution or dilution

Publications (3)

Publication Number	Publication Date
DK1942868T3 DK1942868T3 (da)	2017-06-26
DK1942868T4 true DK1942868T4 (da)	2023-11-06
DK1942868T5 DK1942868T5 (da)	2024-01-08

Family

ID=37801586

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK17166616.7T DK3225233T3 (da)	2005-11-01	2006-10-27	Natriumchloridopløsning til rekonstituering af lægemiddel
DK06827036.2T DK1942868T5 (da)	2005-11-01	2006-10-27	Natriumchloridopløsning til lægemiddel-rekonstitution eller -fortynding

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK17166616.7T DK3225233T3 (da)	2005-11-01	2006-10-27	Natriumchloridopløsning til rekonstituering af lægemiddel

Country Status (31)

Country	Link
US (4)	US20070135343A1 (da)
EP (3)	EP1942868B2 (da)
JP (1)	JP5555425B2 (da)
KR (2)	KR20110128957A (da)
CN (1)	CN101351190B (da)
AR (2)	AR056748A1 (da)
AU (1)	AU2006308921C1 (da)
BR (1)	BRPI0618133A2 (da)
CA (1)	CA2626531C (da)
CR (1)	CR9958A (da)
DK (2)	DK3225233T3 (da)
EC (1)	ECSP088485A (da)
ES (2)	ES2627684T5 (da)
FI (1)	FI1942868T4 (da)
FR (1)	FR20C1005I1 (da)
GT (1)	GT200800037A (da)
HK (1)	HK1245090B (da)
HU (4)	HUE045421T2 (da)
IL (1)	IL190843A (da)
LU (1)	LUC00035I2 (da)
MY (1)	MY184364A (da)
NO (1)	NO347263B1 (da)
NZ (1)	NZ567685A (da)
PE (3)	PE20070714A1 (da)
PL (2)	PL1942868T5 (da)
PT (2)	PT3225233T (da)
RU (1)	RU2432157C2 (da)
SI (2)	SI3225233T1 (da)
TW (1)	TWI480063B (da)
UA (1)	UA97234C2 (da)
WO (1)	WO2007053533A2 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUE045421T2 (hu)	2005-11-01	2019-12-30	Wyeth Llc	Nátrium klorid oldat gyógyszer újraoldására
US7767206B2 (en)	2006-10-02	2010-08-03	Amgen Inc.	Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
US8431011B2 (en) *	2008-01-31	2013-04-30	Abbott Diabetes Care Inc.	Method for automatically and rapidly distinguishing between control and sample solutions in a biosensor strip
CN102665691B (zh) *	2009-11-17	2015-05-27	益普生制药股份有限公司	hGH和rhIGF-1组合的制剂
US9427186B2 (en)	2009-12-04	2016-08-30	Endomagnetics Ltd.	Magnetic probe apparatus
US10634741B2 (en)	2009-12-04	2020-04-28	Endomagnetics Ltd.	Magnetic probe apparatus
ES2753216T3 (es)	2010-01-15	2020-04-07	Amgen K A Inc	Formulación de anticuerpos anti-IL17RA y regímenes terapéuticos para el tratamiento de la psoriasis
NZ602685A (en) *	2010-03-01	2014-10-31	Cytodyn Inc	Concentrated protein formulations and uses thereof
EA037095B1 (ru)	2010-07-09	2021-02-05	Биовератив Терапьютикс Инк.	Способ лечения гемофилии в и эпизодов кровотечения
TWI750197B (zh) *	2012-09-25	2021-12-21	美商百歐維拉提夫治療公司	Ｆｉｘ多肽的應用
AU2014229811B2 (en)	2013-03-11	2018-02-15	Endomagnetics Ltd.	Hypoosmotic solutions for lymph node detection
US9239314B2 (en)	2013-03-13	2016-01-19	Endomagnetics Ltd.	Magnetic detector
US9234877B2 (en)	2013-03-13	2016-01-12	Endomagnetics Ltd.	Magnetic detector
EP2968498A4 (en) *	2013-03-15	2016-09-07	Biogen Ma Inc	FACTOR IX polypeptide formulations
FR3005420B1 (fr) *	2013-05-07	2015-09-18	Erytech Pharma	Procede de stabilisation de suspensions d'erythrocytes encapsulant un principe actif, suspensions obtenues.
SG10201913735SA (en) *	2014-03-24	2020-03-30	Bioverativ Therapeutics Inc	Lyophilized factor ix formulations
US9351945B1 (en)	2015-02-27	2016-05-31	John Daniel Dobak, III	Reduction of adipose tissue
GB2536703B (en) *	2015-03-27	2020-12-02	Ge Healthcare Bio Sciences Ab	Method for baseline correction in a chromatogram
EP3081942A1 (en) *	2015-04-17	2016-10-19	Roche Diagniostics GmbH	Pressure transmission liquid for cellular analyzer, cellular analyzer and method for analyzing a liquid cellular sample
CN107920865B (zh)	2015-06-04	2021-07-09	安都磁学有限公司	用于磁标记定位（mml）的标记材料和形式
US10124021B2 (en) *	2016-12-23	2018-11-13	Andrew L. Gostine	Intravenous fluid
EP3694322B1 (en)	2017-10-09	2024-07-03	Terumo BCT Biotechnologies, LLC	Lyophilization container and method of using same
CA3224729A1 (en)	2019-03-14	2020-09-17	Terumo Bct Biotechnologies, Llc	Lyophilization loading tray assembly and system
US12036187B2 (en) *	2019-05-01	2024-07-16	Southwest Research Institute	Compositions of dimethyl trisulfide (DMTS) as a cyanide antidote
IL272145A (en) *	2020-01-20	2021-07-29	Stem Cell Medicine Ltd	Cosmetic preparations with protein concentrate from a conditioned growth medium of stem cells from adipose tissue
CA3188212A1 (en) *	2020-08-03	2022-02-10	John Pile-Spellman	Devices and methods for trans-arterial osmotic embolization of pathological tissue

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3717708A (en) *	1968-10-24	1973-02-20	Cutter Lab	Blood coagulation complex
US4364861A (en)	1980-05-27	1982-12-21	Cutter Laboratories, Inc.	Blood-coagulation-promoting products and methods of preparing them
US6372716B1 (en)	1994-04-26	2002-04-16	Genetics Institute, Inc.	Formulations for factor IX
RU2244556C2 (ru)	1999-02-22	2005-01-20	Юниверсити Оф Коннектикут	Новые не содержащие альбумин составы фактора viii
US20010031721A1 (en) *	1999-05-05	2001-10-18	Chandra Webb	Highly concentrated, lyophilized, and liquid factor IX formulations
PT1324776E (pt) *	2000-10-12	2009-12-23	Genentech Inc	Formulações de proteína concentradas de viscosidade reduzida
ATE507822T1 (de) *	2003-12-19	2011-05-15	Novo Nordisk Healthcare Ag	Stabilisierte zusammensetzungen von faktor-vii- polypeptiden
US20050226893A1 (en) *	2004-03-04	2005-10-13	Jennifer Juneau	Lyophilization method to improve excipient crystallization
HUE045421T2 (hu)	2005-11-01	2019-12-30	Wyeth Llc	Nátrium klorid oldat gyógyszer újraoldására

2006
- 2006-10-27 HU HUE17166616A patent/HUE045421T2/hu unknown
- 2006-10-27 NO NO20082180A patent/NO347263B1/no unknown
- 2006-10-27 CA CA2626531A patent/CA2626531C/en active Active
- 2006-10-27 HU HUE06827036A patent/HUE033949T2/hu unknown
- 2006-10-27 SI SI200632348T patent/SI3225233T1/sl unknown
- 2006-10-27 PL PL06827036.2T patent/PL1942868T5/pl unknown
- 2006-10-27 PE PE2006001318A patent/PE20070714A1/es not_active Application Discontinuation
- 2006-10-27 PL PL17166616T patent/PL3225233T3/pl unknown
- 2006-10-27 US US11/589,002 patent/US20070135343A1/en not_active Abandoned
- 2006-10-27 MY MYPI20081347A patent/MY184364A/en unknown
- 2006-10-27 KR KR1020117027131A patent/KR20110128957A/ko not_active Application Discontinuation
- 2006-10-27 UA UAA200807432A patent/UA97234C2/ru unknown
- 2006-10-27 EP EP06827036.2A patent/EP1942868B2/en active Active
- 2006-10-27 NZ NZ567685A patent/NZ567685A/en unknown
- 2006-10-27 ES ES06827036T patent/ES2627684T5/es active Active
- 2006-10-27 EP EP19189599.4A patent/EP3593790A1/en not_active Withdrawn
- 2006-10-27 PE PE2011000653A patent/PE20110803A1/es not_active Application Discontinuation
- 2006-10-27 AU AU2006308921A patent/AU2006308921C1/en active Active
- 2006-10-27 TW TW095139724A patent/TWI480063B/zh active
- 2006-10-27 BR BRPI0618133-3A patent/BRPI0618133A2/pt not_active Application Discontinuation
- 2006-10-27 ES ES17166616T patent/ES2749574T3/es active Active
- 2006-10-27 CN CN2006800400807A patent/CN101351190B/zh active Active
- 2006-10-27 PT PT171666167T patent/PT3225233T/pt unknown
- 2006-10-27 WO PCT/US2006/042258 patent/WO2007053533A2/en active Application Filing
- 2006-10-27 DK DK17166616.7T patent/DK3225233T3/da active
- 2006-10-27 PE PE2015001729A patent/PE20151284A1/es not_active Application Discontinuation
- 2006-10-27 EP EP17166616.7A patent/EP3225233B1/en not_active Revoked
- 2006-10-27 RU RU2008119514/15A patent/RU2432157C2/ru active
- 2006-10-27 KR KR1020087013252A patent/KR101126670B1/ko active IP Right Grant
- 2006-10-27 DK DK06827036.2T patent/DK1942868T5/da active
- 2006-10-27 PT PT68270362T patent/PT1942868T/pt unknown
- 2006-10-27 JP JP2008538945A patent/JP5555425B2/ja active Active
- 2006-10-27 SI SI200632172T patent/SI1942868T2/sl unknown
- 2006-10-31 AR ARP060104769A patent/AR056748A1/es not_active Application Discontinuation
2008
- 2008-04-14 IL IL190843A patent/IL190843A/en active IP Right Grant
- 2008-04-17 GT GT200800037A patent/GT200800037A/es unknown
- 2008-05-07 CR CR9958A patent/CR9958A/es not_active Application Discontinuation
- 2008-05-30 EC EC2008008485A patent/ECSP088485A/es unknown
2016
- 2016-10-07 US US15/288,860 patent/US20170021022A1/en not_active Abandoned
2017
- 2017-09-25 LU LU00035C patent/LUC00035I2/fr unknown
- 2017-09-27 HU HUS1700035C patent/HUS1700035I1/hu unknown
2018
- 2018-04-04 HK HK18104477.4A patent/HK1245090B/zh unknown
- 2018-07-06 AR ARP180101902 patent/AR112443A2/es not_active Application Discontinuation
2019
- 2019-12-20 US US16/723,563 patent/US20200138952A1/en not_active Abandoned
2020
- 2020-01-31 HU HUS2000003C patent/HUS2000003I1/hu unknown
- 2020-02-10 FR FR20C1005C patent/FR20C1005I1/fr active Active
- 2020-07-14 US US16/946,998 patent/US20200338199A1/en not_active Abandoned
2023
- 2023-03-17 FI FIEP06827036.2T patent/FI1942868T4/fi active

Also Published As

Publication number	Publication date
PE20070714A1 (es)	2007-07-20
CA2626531C (en)	2011-11-29
PL3225233T3 (pl)	2019-12-31
FR20C1005I1 (fr)	2020-03-20
EP1942868B2 (en)	2023-10-04
NO347263B1 (no)	2023-08-14
US20170021022A1 (en)	2017-01-26
LUC00035I1 (da)	2017-09-28
CN101351190B (zh)	2013-01-02
ES2627684T3 (es)	2017-07-31
ECSP088485A (es)	2008-06-30
HK1245090B (zh)	2020-04-09
MY184364A (en)	2021-04-01
DK1942868T3 (da)	2017-06-26
AR112443A2 (es)	2019-10-30
BRPI0618133A2 (pt)	2011-08-16
UA97234C2 (ru)	2012-01-25
US20070135343A1 (en)	2007-06-14
PL1942868T5 (pl)	2023-12-27
AU2006308921B2 (en)	2012-07-19
KR20080065689A (ko)	2008-07-14
PE20110803A1 (es)	2011-11-07
FI1942868T4 (fi)	2023-10-12
IL190843A0 (en)	2008-11-03
US20200338199A1 (en)	2020-10-29
JP2009513705A (ja)	2009-04-02
HUS1700035I1 (hu)	2017-11-28
WO2007053533A3 (en)	2007-12-06
RU2008119514A (ru)	2009-12-10
EP3225233B1 (en)	2019-08-14
EP1942868B1 (en)	2017-04-19
JP5555425B2 (ja)	2014-07-23
AR056748A1 (es)	2007-10-24
PE20151284A1 (es)	2015-10-05
NZ567685A (en)	2011-07-29
US20200138952A1 (en)	2020-05-07
DK3225233T3 (da)	2019-10-14
WO2007053533A8 (en)	2008-07-24
DK1942868T5 (da)	2024-01-08
LUC00035I2 (da)	2017-12-01
CR9958A (es)	2008-07-29
GT200800037A (es)	2008-10-01
HUS2000003I1 (hu)	2020-02-28
HUE045421T2 (hu)	2019-12-30
EP1942868A2 (en)	2008-07-16
ES2749574T3 (es)	2020-03-23
PL1942868T3 (pl)	2017-09-29
SI3225233T1 (sl)	2019-10-30
HUE033949T2 (hu)	2018-01-29
TW200803915A (en)	2008-01-16
TWI480063B (zh)	2015-04-11
AU2006308921C1 (en)	2013-01-24
WO2007053533A2 (en)	2007-05-10
NO20082180A (no)	2008-07-04
AU2006308921A1 (en)	2007-05-10
IL190843A (en)	2013-08-29
KR20110128957A (ko)	2011-11-30
CA2626531A1 (en)	2007-05-10
SI1942868T2 (sl)	2023-12-29
EP3225233A1 (en)	2017-10-04
RU2432157C2 (ru)	2011-10-27
NO20082180L (no)	2008-07-04
ES2627684T5 (es)	2024-04-29
SI1942868T1 (sl)	2017-07-31
PT3225233T (pt)	2019-10-24
KR101126670B1 (ko)	2012-04-23
PT1942868T (pt)	2017-06-16
EP3593790A1 (en)	2020-01-15
CN101351190A (zh)	2009-01-21

Publication	Publication Date	Title
DK1942868T4 (da)	2023-11-06	Natriumchloridopløsning til lægemiddel-rekonstitution eller -fortynding
NO2018037I1 (no)	2018-10-24	Simeprevir, eller salt derav, innbefattende natrium-simeprevir
FIC20210018I1 (fi)	2021-06-14	Cenobamat eller ett farmaceutiskt salt därav
NL300885I2 (nl)	2022-02-24	Irinotecansucrosofaatzout
DE602006012117D1 (de)	2010-03-25	Gewebe-wiederherstellungssystem
NL2000480A1 (nl)	2007-08-20	Nieuwe farmaceutische middelen.
EP1872294A4 (en)	2010-10-27	VIRTUAL EARTH
DK1856042T3 (da)	2012-09-17	Substituerede gamma-lactamer som terapeutiske midler
DE602004006612D1 (de)	2007-07-05	Freifliessendes Fördersystem
DE602006020294D1 (de)	2011-04-07	Heterozyklische verbindung
EP1873153A4 (en)	2009-09-30	HETEROCYCLIC COMPOUND
DE602006004919D1 (de)	2009-03-12	Endoskopsystem
DE602006016764D1 (de)	2010-10-21	Medizinisches Telemetriesystem
FR2888006B1 (fr)	2011-03-04	Systeme radiographique
FI20065708A0 (fi)	2006-11-10	Laitteisto yksillöllisesti muotoiltujen jalkineiden suunnittelemiseksi
DE602005027499D1 (de)	2011-05-26	Endoskopsystem
BRPI0719916A2 (pt)	2014-03-04	Recuperação de cloreto de tritila
FI20050365A (fi)	2006-10-12	Tietokonetomografialaitteisto
DE602006014221D1 (de)	2010-06-17	Kreiselgerät
FI20055349A0 (fi)	2005-06-27	Hälytinjärjestelmä
DE502006001141D1 (de)	2008-08-28	Sicherheitssystem
DK1934388T3 (da)	2013-02-25	Fremgangsmåde til lægemiddeludvikling
DE502005009502D1 (de)	2010-06-10	Sicherheitssystem
ITMI20052367A1 (it)	2007-06-14	Cristallizzatore
ES1061996Y (es)	2006-08-01	Arado de laboreo entre cepas.